Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MiMedx Group, Inc.(MDXG) | 0 | 28,195,249 | +28,195,249 | $0 | $247.27M | 61.19% | +$247.27M |
| Bioventus Inc.CL A(BVS) | 13,021,324 | 13,021,324 | 0 | $42.97M | $68.62M | 16.98% | +$25.65M |
| EyePoint, Inc.(EYPT) | 3,490,921 | 2,337,786 | -1,153,135 | $27.89M | $54.03M | 13.37% | +$26.13M |
| TELA Bio, Inc.(TELA) | 4,110,709 | 4,110,709 | 0 | $32.89M | $27.21M | 6.73% | -$5.67M |
| Revance Therapeutics Inc | 457,085 | 457,085 | 0 | $5.24M | $4.02M | 0.99% | -$1.22M |
| MediciNova, Inc.(MNOV) | 1,105,941 | 1,105,941 | 0 | $2.31M | $1.66M | 0.41% | -$652.5K |
| Venus Concept, Inc. | 1,089,195 | 1,089,190 | -5 | $2.13M | $1.29M | 0.32% | -$849.6K |